结直肠癌肝转移的管理中的演变和当前趋势
Premila D Leiphrakpam1,2, Rachael Newton3, Daniel A Anaya4
1Graduate Medical Education, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
Minerva surgery
|July 2, 2024
概括
转移性结直肠癌肝转移 (CRLM) 的管理是复杂的,因为患者的异质性. 多学科团队方法对于个性化治疗和改善CRLM生存结果至关重要.
科学领域:
- 在瘤学瘤学.
- 手术瘤学手术瘤学
- 胃肠病学 胃肠病学
背景情况:
- 转移性结直肠癌 (mCRC) 对与癌症相关的死亡率有显著的贡献,肝转移 (CRLM) 是最常见的.
- 大约50%的结直肠癌患者患有肝转移,影响整体生存率.
- 完整的肝切除为切除的CRLM提供了最好的生存率,但在诊断时只有15-20%是候选人.
研究的目的:
- 要突出评估结直肠癌肝转移 (CRLM) 治疗方案的复杂性.
- 强调在管理CRLM时需要采用多学科的团队方法.
- 讨论CRLM管理策略的演变.
主要方法:
- 审查CRLM目前的治疗方式,包括手术切除,全身疗法和局部区域治疗.
- 对切除的患者选择标准的分析以及无法切除的疾病所带来的挑战.
- 讨论多学科团队 (MDT) 在治疗规划中的重要性.
主要成果:
- 完全切除肝脏可为切除的CRLM提供高达5年生存率的58%.
- 即使在最佳化疗中,不可切除的CRLM的中位生存率仍然很低.
- 不断发展的管理包括扩大切除标准,向疗法和先进的局部区域治疗.
结论:
- 由于患者异质性,CRLM的最佳管理是复杂的.
- 多学科团队对于定义切除能力和个性化治疗至关重要.
- 个性化治疗策略对于CRLM患者来说,从诊断到治疗结束至关重要.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Esophageal Varices-II: Clinical Features and Management
57
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
57
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


